Cargando…
An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats
In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredien...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457137/ https://www.ncbi.nlm.nih.gov/pubmed/32922299 http://dx.doi.org/10.3389/fphar.2020.01295 |
_version_ | 1783575943439187968 |
---|---|
author | Shi, Peiying Xie, Yunjiao Xie, Rongfang Lin, Zuan Yao, Hong Wu, Shuang |
author_facet | Shi, Peiying Xie, Yunjiao Xie, Rongfang Lin, Zuan Yao, Hong Wu, Shuang |
author_sort | Shi, Peiying |
collection | PubMed |
description | In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredients in ASEP with high contents and detectable property in rat plasma were selected. Next, the PK study of the resulted ingredients was performed in rats (1.76 ml/kg and 3.52 ml/kg of 5 times concentrated ASEP, single i.v.). Meanwhile, the drug targets for the ingredients screened out were predicted by using a target fishing online server, PharmMapper (http://www.lilab-ecust.cn/pharmmapper/) with a fit filtration threshold of z’-score >0. Next, the network pharmacology, molecular docking, diseases ontology (DO) analysis, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed respectively for the predicted targets. Finally, the supporting evidences were obtained to characterize the PK markers and carry out the integrated PK study with “plasma-drug concentration sum” or “plasma-drug AUC weighted” methods. As a result, 6 ingredients, involving 5-caffeoylquinic acid (5-CQA), 3-CQA, 4-CQA, protocatechuic acid, eleutheroside B, and gentiopicroside were selected, and their PK profiles were elucidated. The 6 ingredients were highly related to arteriosclerotic cardiovascular disease and atherosclerosis and could mainly interact with similar targets, e.g., GSK3B, PDPK1, PLAU, etc., or pathways, e.g., Insulin, VEGF, FoxO, etc, providing the basis for integrating plasma drug concentration. Ultimately, the 6 ingredients were considered as PK markers and the whole in vivo process of ASEP were characterized. Our study would enhance understanding of the therapeutic effects and mechanisms of ASEP against cardiovascular diseases, and provided useful insights for future integrated PK study on anti-cardiovascular diseases TCM injections. |
format | Online Article Text |
id | pubmed-7457137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74571372020-09-11 An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats Shi, Peiying Xie, Yunjiao Xie, Rongfang Lin, Zuan Yao, Hong Wu, Shuang Front Pharmacol Pharmacology In this paper, the integrated pharmacokinetics (PK) of an Acanthopanax senticosus extract preparation (ASEP, named as Ciwujia injection in clinic in China) was explored by combining with multi-component PK in rats, virtual screening, systems pharmacology and molecular docking. Firstly, the ingredients in ASEP with high contents and detectable property in rat plasma were selected. Next, the PK study of the resulted ingredients was performed in rats (1.76 ml/kg and 3.52 ml/kg of 5 times concentrated ASEP, single i.v.). Meanwhile, the drug targets for the ingredients screened out were predicted by using a target fishing online server, PharmMapper (http://www.lilab-ecust.cn/pharmmapper/) with a fit filtration threshold of z’-score >0. Next, the network pharmacology, molecular docking, diseases ontology (DO) analysis, and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed respectively for the predicted targets. Finally, the supporting evidences were obtained to characterize the PK markers and carry out the integrated PK study with “plasma-drug concentration sum” or “plasma-drug AUC weighted” methods. As a result, 6 ingredients, involving 5-caffeoylquinic acid (5-CQA), 3-CQA, 4-CQA, protocatechuic acid, eleutheroside B, and gentiopicroside were selected, and their PK profiles were elucidated. The 6 ingredients were highly related to arteriosclerotic cardiovascular disease and atherosclerosis and could mainly interact with similar targets, e.g., GSK3B, PDPK1, PLAU, etc., or pathways, e.g., Insulin, VEGF, FoxO, etc, providing the basis for integrating plasma drug concentration. Ultimately, the 6 ingredients were considered as PK markers and the whole in vivo process of ASEP were characterized. Our study would enhance understanding of the therapeutic effects and mechanisms of ASEP against cardiovascular diseases, and provided useful insights for future integrated PK study on anti-cardiovascular diseases TCM injections. Frontiers Media S.A. 2020-08-14 /pmc/articles/PMC7457137/ /pubmed/32922299 http://dx.doi.org/10.3389/fphar.2020.01295 Text en Copyright © 2020 Shi, Xie, Xie, Lin, Yao and Wu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Shi, Peiying Xie, Yunjiao Xie, Rongfang Lin, Zuan Yao, Hong Wu, Shuang An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title | An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title_full | An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title_fullStr | An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title_full_unstemmed | An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title_short | An Integrated Pharmacokinetic Study of an Acanthopanax senticosus Extract Preparation by Combination of Virtual Screening, Systems Pharmacology, and Multi-Component Pharmacokinetics in Rats |
title_sort | integrated pharmacokinetic study of an acanthopanax senticosus extract preparation by combination of virtual screening, systems pharmacology, and multi-component pharmacokinetics in rats |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457137/ https://www.ncbi.nlm.nih.gov/pubmed/32922299 http://dx.doi.org/10.3389/fphar.2020.01295 |
work_keys_str_mv | AT shipeiying anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT xieyunjiao anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT xierongfang anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT linzuan anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT yaohong anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT wushuang anintegratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT shipeiying integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT xieyunjiao integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT xierongfang integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT linzuan integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT yaohong integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats AT wushuang integratedpharmacokineticstudyofanacanthopanaxsenticosusextractpreparationbycombinationofvirtualscreeningsystemspharmacologyandmulticomponentpharmacokineticsinrats |